أبحاث السرطان

(تم التحويل من Cancer research)
هذا المقال هو عن research into cancer, in general. إذا كنت تريد the UK-based charity، انظر Cancer Research UK. إذا كنت تريد the journal، انظر Cancer Research (journal).

Cancer research is research into cancer to identify causes and develop strategies for prevention, diagnosis, treatment, and cure.

Cancer research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. These applications include surgery, radiation therapy, chemotherapy, hormone therapy, immunotherapy and combined treatment modalities such as chemo-radiotherapy. Starting in the mid-1990s, the emphasis in clinical cancer research shifted towards therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy.

Cancer research is done in academia, research institutes, and corporate environments, and is largely government funded.[بحاجة لمصدر]

History

Sidney Farber is regarded as the father of modern chemotherapy.

Cancer research has been ongoing for centuries. Early research focused on the causes of cancer.[1] Percivall Pott identified the first environmental trigger (chimney soot) for cancer in 1775 and cigarette smoking was identified as a cause of lung cancer in 1950. Early cancer treatment focused on improving surgical techniques for removing tumors. Radiation therapy took hold in the 1900s. Chemotherapeutics were developed and refined throughout the 20th century.

The U.S. declared a "War on Cancer" in the 1970s, and increased the funding and support for cancer research.[2]


Seminal papers

Some of the most highly cited and most influential research reports include:

Types of research

Cancer research encompasses a variety of types and interdisciplinary areas of research. Scientists involved in cancer research may be trained in areas such as chemistry, biochemistry, molecular biology, physiology, medical physics, epidemiology, and biomedical engineering. Research performed on a foundational level is referred to as basic research and is intended to clarify scientific principles and mechanisms. Translational research aims to elucidate mechanisms of cancer development and progression and transform basic scientific findings into concepts that can be applicable to the treatment and prevention of cancer. Clinical research is devoted to the development of pharmaceuticals, surgical procedures, and medical technologies for the eventual treatment of patients.

Prevention and epidemiology

Epidemiologic analysis indicates that at least 35% of all cancer deaths in the world could now be avoided by primary prevention.[3] According to a newer GBD systematic analysis, in 2019, ~44% of all cancer deaths — or ~4.5 million deaths or ~105 million lost disability-adjusted life years — were due to known clearly preventable risk factors, led by smoking, alcohol use and high BMI.[4]

However, one 2015 study suggested that between ~70% and ~90% of cancers are due to environmental factors and therefore potentially preventable.[5][contradictory] Furthermore, it is estimated that with further research cancer death rates could be reduced by 70% around the world even without the development of any new therapies.[3] Cancer prevention research receives only 2–9% of global cancer research funding,[3] albeit many of the options for prevention are already well-known without further cancer-specific research but are not reflected in economics and policy. Mutational signatures of various cancers, for example, could reveal further causes of cancer and support causal attribution.[6][بحاجة لمصادر إضافية]

Detection

للمزيد من المعلومات: Cancer screening
انظر أيضاً: Biomarker

Prompt detection of cancer is important, since it is usually more difficult to treat in later stages. Accurate detection of cancer is also important because false positives can cause harm from unnecessary medical procedures. Some screening protocols are currently not accurate (such as prostate-specific antigen testing). Others such as a colonoscopy or mammogram are unpleasant and as a result some patients may opt out. Active research is underway to address all these problems, to develop novel ways of cancer screening and to increase detection rates.[بحاجة لمصدر]

For example:

Treatment

المقالة الرئيسية: Treatment of cancer

Emerging topics of cancer treatment research include:

Cause and development of cancer

Numerous cell signaling pathways are disrupted in the development of cancer.

Research into the cause of cancer involves many different disciplines including genetics, diet, environmental factors (i.e. chemical carcinogens). In regard to investigation of causes and potential targets for therapy, the route used starts with data obtained from clinical observations, enters basic research, and, once convincing and independently confirmed results are obtained, proceeds with clinical research, involving appropriately designed trials on consenting human subjects, with the aim to test safety and efficiency of the therapeutic intervention method. An important part of basic research is characterization of the potential mechanisms of carcinogenesis, in regard to the types of genetic and epigenetic changes that are associated with cancer development. The mouse is often used as a mammalian model for manipulation of the function of genes that play a role in tumor formation, while basic aspects of tumor initiation, such as mutagenesis, are assayed on cultures of bacteria and mammalian cells.

Genes involved in cancer

المقالة الرئيسية: Oncogenomics
انظر أيضاً: Databases for oncogenomic research

The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. As the Cancer Genome Project stated in a 2004 review article, "a central aim of cancer research has been to identify the mutated genes that are causally implicated in oncogenesis (cancer genes)."[32] The Cancer Genome Atlas project is a related effort investigating the genomic changes associated with cancer, while the COSMIC cancer database documents acquired genetic mutations from hundreds of thousands of human cancer samples.[33]

These large scale projects, involving about 350 different types of cancer, have identified ~130,000 mutations in ~3000 genes that have been mutated in the tumors. The majority occurred in 319 genes, of which 286 were tumor suppressor genes and 33 oncogenes.

Several hereditary factors can increase the chance of cancer-causing mutations, including the activation of oncogenes or the inhibition of tumor suppressor genes. The functions of various onco- and tumor suppressor genes can be disrupted at different stages of tumor progression. Mutations in such genes can be used to classify the malignancy of a tumor.

In later stages, tumors can develop a resistance to cancer treatment. The identification of oncogenes and tumor suppressor genes is important to understand tumor progression and treatment success. The role of a given gene in cancer progression may vary tremendously, depending on the stage and type of cancer involved.[34]

Cancer epigenetics

page-not-found

Diet and cancer

This section is an excerpt from النظام الغذائي والسرطان.[تحرير]
يشير هذا الإعلان إلى أن النظام الغذائي الصحي يساعد في الوقاية من السرطان.

من المسلم به أن العوامل الغذائية لها تأثير كبير على خطر الإصابة بالسرطانات، حيث تعمل العناصر الغذائية المختلفة على زيادة أو الحد من خطر الإصابة. قد يرتبط النظام الغذائي والبدانة بأكثر من 30-35% من وفيات السرطان،[35] بينما تبين أن الخمول البدني يرتب بـ7% من خطر حدوث السرطان.[36] اقترحت دورية نشرت عام 2011 أن إجمالي السعرات الحرارية المتناولة يؤثر على حدوث السرطان وربما تطوره.[37]

في حين اقترحت العديد من التوصيات الغذائية للحد من خطر الإصابة بالسرطان، إلا أن القليل منها مرفق بأدلة علمية داعمة هامة.[37] ترتبط البدانة وتناول المشروبات الكحولية بالإصابة وتطور بعض أنواع السرطانات.[37] يوصى بالتقليل من شرب المشروبات المحلاة بالسكر كتدبير لمعالجة البدانة.[38] النظام الغذائي الذي يحتوي على كميات قليلة من الفواكه والخضروات وكميات كبيرة من اللحوم الحمراء، يسهم-ولكن ليس بشكل مؤكد-في الإصابة بالسرطان،[39] وقد يكون التأثير ضئيلاً على الأشخاص الذين يتغذون جيداً ويحافظون على وزنهم الصحي.[37]

ترتبط بعض أنواع الأغذية بأنواع محددة من السرطان. أظهرت الدراسات العلاقة بين تناول اللحوم المعالجة والحمراء في زيادة خطر الإصابة بسرطان الثدي، سرطان القولون، [38] سرطان الپروستاتا،[40] وسرطان الپنكرياس، الأمر الذي يفسر جزئياً لوجود المسرطان في الأغذية المطهوة على درجات حرارة مرتفعة.[41][42] أفلاتوكسين ب1، الملوث الغذائي الشائع، يزيد من خطر الإصابة بسرطان الكبد،[43] بينما يرتبط تناول القهوة بانخفاض خطر الإصابة به.[44] مضغ جوز الأركا قد يسبب سرطان الفم.[43] سرطان المعدة أكثر شيوعاً في اليابان بسبب النظام الغذائي الذي يحتوي على كميات كبيرة من الملح.[43][45] تظهر تجمعات المهاجرين ميلاً إلى تطوير خطر الإصابة في بلدهم الجديد، وغالباً ما يظهر ذلك في غضون جيل واحد، مما يشير إلى وجود صلة جوهرية بين النظام الغذائي والسرطان.[46]

عادة ما تتضمن التوصيات الغذائية للوقاية من السرطان الحفاظ على الوزن وتناول "الخضروات، الفواكه، الحبوب الكاملة والأسماك، بشكل رئيسي، وتناول كميات قليلة من اللحوم الحمراء، الدهون الحيوانية، والسكر المكرر".[37]

Periods of intermittent fasting (time-restricted feeding which may not include caloric restriction) is investigated for potential usefulness in cancer prevention and treatment and as of 2021 additional trials are needed to elucidate the risks and benefits.[47][48][49][50] In some cases, "caloric restrictions could hinder both cancer growth and progression, besides enhancing the efficacy of chemotherapy and radiation therapy".[51] Caloric restriction mimetics, including some present in foods like spermidine, are also investigated for these or similar reasons.[52][53] Such and similar dietary supplements may contribute to prevention or treatment, with candidate substances including apigenin,[54][55][56] berberine,[57][58][59][60][61] jiaogulan,[62] and rhodiola rosea.[63][64]


Research funding

انظر أيضاً: Global health and Funding of science

Cancer research is funded by government grants, charitable foundations and pharmaceutical and biotechnology companies.[65]

In the early 2000s, most funding for cancer research came from taxpayers and charities, rather than from corporations. In the US, less than 30% of all cancer research was funded by commercial researchers such as pharmaceutical companies.[66] Per capita, public spending on cancer research by taxpayers and charities in the US was five times as much in 2002–03 as public spending by taxpayers and charities in the 15 countries that were full members of the European Union.[66] As a percentage of GDP, the non-commercial funding of cancer research in the US was four times the amount dedicated to cancer research in Europe.[66] Half of Europe's non-commercial cancer research is funded by charitable organizations.[66]

The National Cancer Institute is the major funding institution in the United States. In the 2023 fiscal year, the NCI funded $7.1 billion in cancer research.[67]

صعوبات

Difficulties inherent to cancer research are shared with many types of biomedical research.

Cancer research processes have been criticised. These include, especially in the US, for the financial resources and positions required to conduct research. Other consequences of competition for research resources appear to be a substantial number of research publications whose results cannot be replicated.[68][69][70][71]

إمكانية النسخ

page-not-found

Public participation

Distributed computing

One can share computer time for distributed cancer research projects like Help Conquer Cancer.[72] World Community Grid also had a project called Help Defeat Cancer. Other related projects include the Folding@home and Rosetta@home projects, which focus on groundbreaking protein folding and protein structure prediction research. Vodafone has also partnered with the Garvan Institute to create the DreamLab Project, which uses distributed computing via an app on cellphones to perform cancer research.

Clinical trials

MatchMiner overview of data flow and modes of use[73]

Members of the public can also join clinical trials as healthy control subjects or for methods of cancer detection.

There could be software and data-related procedures that increase participation in trials and make them faster and less expensive. One open source platform matches genomically profiled cancer patients to precision medicine drug trials.[74][73]

MD Anderson Cancer Center is ranked as one of the top cancer research institutions.

Organizations

Breast cancer awareness ribbon statue in Kentucky

Organizations exist as associations for scientists participating in cancer research, such as the American Association for Cancer Research and American Society of Clinical Oncology, and as foundations for public awareness or raising funds for cancer research, such as Relay For Life and the American Cancer Society.

Awareness campaigns

Supporters of different types of cancer have adopted different colored awareness ribbons and promote months of the year as being dedicated to the support of specific types of cancer.[75] The American Cancer Society began promoting October as Breast Cancer Awareness Month in the United States in the 1980s. Pink products are sold to both generate awareness and raise money to be donated for research purposes. This has led to pinkwashing, or the selling of ordinary products turned pink as a promotion for the company.

See also

References

  1. ^ "Early Theories about Cancer Causes". American Cancer Society. Archived from the original on 9 مايو 2018. Retrieved 9 مايو 2018.
  2. ^ "Milestone (1971): President Nixon declares war on cancer". dtp.cancer.gov. Archived from the original on 3 ديسمبر 2017. Retrieved 9 مايو 2018.
  3. ^ أ ب ت Song M, Vogelstein B, Giovannucci EL, Willett WC, Tomasetti C (سبتمبر 2018). "Cancer prevention: Molecular and epidemiologic consensus". Science. 361 (6409): 1317–8. Bibcode:2018Sci...361.1317S. doi:10.1126/science.aau3830. PMC 6260589. PMID 30262488.
  4. ^ Tran, Khanh Bao; Lang, Justin J.; Compton, Kelly; Xu, Rixing; Acheson, Alistair R.; Henrikson, Hannah Jacqueline; Kocarnik, Jonathan M.; Penberthy, Louise; Aali, Amirali; Abbas, Qamar; et al. (20 أغسطس 2022). "The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet. 400 (10352): 563–591. doi:10.1016/S0140-6736(22)01438-6. PMC 9395583. PMID 35988567.
  5. ^ Wu S, Powers S, Zhu W, Hannun YA (يناير 2016). "Substantial contribution of extrinsic risk factors to cancer development". Nature. 529 (7584): 43–7. Bibcode:2016Natur.529...43W. doi:10.1038/nature16166. PMC 4836858. PMID 26675728.
  6. ^ Degasperi, Andrea; Zou, Xueqing; Dias Amarante, Tauanne; Martinez-Martinez, Andrea; et al. (22 أبريل 2022). "Substitution mutational signatures in whole-genome–sequenced cancers in the UK population". Science. 376 (6591): abl9283. doi:10.1126/science.abl9283. PMC 7613262. PMID 35949260. S2CID 248334490.
  7. ^ خطأ: لا توجد وحدة بهذا الاسم "cite news".
  8. ^ Chen, Richard J.; Lu, Ming Y.; Williamson, Drew F. K.; Chen, Tiffany Y.; Lipkova, Jana; Noor, Zahra; Shaban, Muhammad; Shady, Maha; Williams, Mane; Joo, Bumjin; Mahmood, Faisal (8 أغسطس 2022). "Pan-cancer integrative histology-genomic analysis via multimodal deep learning". Cancer Cell. 40 (8): 865–878.e6. doi:10.1016/j.ccell.2022.07.004. PMC 10397370. PMID 35944502. S2CID 251456162.
  9. ^ Zimmer, Carl (29 سبتمبر 2022). "A New Approach to Spotting Tumors: Look for Their Microbes". The New York Times. Retrieved 19 أكتوبر 2022.
  10. ^ Dohlman, Anders B.; Klug, Jared; Mesko, Marissa; Gao, Iris H.; Lipkin, Steven M.; Shen, Xiling; Iliev, Iliyan D. (29 سبتمبر 2022). "A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors". Cell. 185 (20): 3807–22. doi:10.1016/j.cell.2022.09.015. PMC 9564002. PMID 36179671.
  11. ^ Narunsky-Haziza, Lian; Sepich-Poore, Gregory D.; Livyatan, Ilana; Asraf, Omer; Martino, Cameron; Nejman, Deborah; Gavert, Nancy; Stajich, Jason E.; Amit, Guy; González, Antonio; Wandro, Stephen; Perry, Gili; Ariel, Ruthie; Meltser, Arnon; Shaffer, Justin P.; Zhu, Qiyun; Balint-Lahat, Nora; Barshack, Iris; Dadiani, Maya; Gal-Yam, Einav N.; Patel, Sandip Pravin; Bashan, Amir; Swafford, Austin D.; Pilpel, Yitzhak; Knight, Rob; Straussman, Ravid (29 سبتمبر 2022). "Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions". Cell. 185 (20): 3789–3806.e17. doi:10.1016/j.cell.2022.09.005. PMC 9567272. PMID 36179670.
  12. ^ Piqueret, Baptiste; Montaudon, Élodie; Devienne, Paul; Leroy, Chloé; Marangoni, Elisabetta; Sandoz, Jean-Christophe; d'Ettorre, Patrizia (25 يناير 2023). "Ants act as olfactory bio-detectors of tumours in patient-derived xenograft mice". Proceedings of the Royal Society B: Biological Sciences. 290 (1991): 20221962. doi:10.1098/rspb.2022.1962. PMC 9874262. PMID 36695032.
  13. ^ di Pietro A, Tosti G, Ferrucci PF, Testori A (ديسمبر 2008). "Oncophage: step to the future for vaccine therapy in melanoma". Expert Opinion on Biological Therapy. 8 (12): 1973–84. doi:10.1517/14712590802517970. PMID 18990084. S2CID 83589014.
  14. ^ Chen, Kok-Siong; Reinshagen, Clemens; Van Schaik, Thijs A.; Rossignoli, Filippo; Borges, Paulo; Mendonca, Natalia Claire; Abdi, Reza; Simon, Brennan; Reardon, David A.; Wakimoto, Hiroaki; Shah, Khalid (4 يناير 2023). "Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity". Science Translational Medicine. 15 (677): eabo4778. doi:10.1126/scitranslmed.abo4778. PMC 10068810. PMID 36599004. S2CID 255416438.
  15. ^ "Gene Therapy, Cancer-Killing Viruses And New Drugs Highlight Novel Approaches To Cancer Treatment". Medical News Today. Retrieved 24 أبريل 2007.
  16. ^ "World first gene therapy trial for leukaemia". LLR. Archived from the original on 2 أغسطس 2013. Retrieved 23 يوليو 2013.
  17. ^ Chinese scientists to pioneer first human CRISPR trial
  18. ^ Schmidt, Christine K.; Medina-Sánchez, Mariana; Edmondson, Richard J.; Schmidt, Oliver G. (5 نوفمبر 2020). "Engineering microrobots for targeted cancer therapies from a medical perspective". Nature Communications (in الإنجليزية). 11 (1): 5618. Bibcode:2020NatCo..11.5618S. doi:10.1038/s41467-020-19322-7. ISSN 2041-1723. PMC 7645678. PMID 33154372.
  19. ^ Gwisai, T.; Mirkhani, N.; Christiansen, M. G.; Nguyen, T. T.; Ling, V.; Schuerle, S. (26 أكتوبر 2022). "Magnetic torque–driven living microrobots for increased tumor infiltration". Science Robotics (in الإنجليزية). 7 (71): eabo0665. bioRxiv 10.1101/2022.01.03.473989. doi:10.1126/scirobotics.abo0665. ISSN 2470-9476. PMID 36288270. S2CID 253160428.
  20. ^ Kishore, Chandra; Bhadra, Priyanka (يوليو 2021). "Targeting Brain Cancer Cells by Nanorobot, a Promising Nanovehicle: New Challenges and Future Perspectives". CNS & Neurological Disorders Drug Targets. 20 (6): 531–9. doi:10.2174/1871527320666210526154801. PMID 34042038. S2CID 235217854.
  21. ^ Contreras-Llano, Luis E.; Liu, Yu-Han; Henson, Tanner; Meyer, Conary C.; Baghdasaryan, Ofelya; Khan, Shahid; Lin, Chi-Long; Wang, Aijun; Hu, Che-Ming J.; Tan, Cheemeng (11 يناير 2023). "Engineering Cyborg Bacteria Through Intracellular Hydrogelation". Advanced Science (in الإنجليزية). 10 (9): 2204175. doi:10.1002/advs.202204175. ISSN 2198-3844. PMC 10037956. PMID 36628538.
  22. ^ Lawler, Sean E.; Speranza, Maria-Carmela; Cho, Choi-Fong; Chiocca, E. Antonio (1 يونيو 2017). "Oncolytic Viruses in Cancer Treatment: A Review". JAMA Oncology. 3 (6): 841–9. doi:10.1001/jamaoncol.2016.2064. PMID 27441411. S2CID 39321536.
  23. ^ Harrington, Kevin; Freeman, Daniel J.; Kelly, Beth; Harper, James; Soria, Jean-Charles (سبتمبر 2019). "Optimizing oncolytic virotherapy in cancer treatment". Nature Reviews Drug Discovery (in الإنجليزية). 18 (9): 689–706. doi:10.1038/s41573-019-0029-0. ISSN 1474-1784. PMID 31292532. S2CID 256745869.
  24. ^ Osborne, Margaret. "Small Cancer Trial Resulted in Complete Remission for All Participants". Smithsonian Magazine (in الإنجليزية). Retrieved 21 يوليو 2022.
  25. ^ Cercek, Andrea; Lumish, Melissa; Sinopoli, Jenna; Weiss, Jill; Shia, Jinru; Lamendola-Essel, Michelle; El Dika, Imane H.; Segal, Neil; Shcherba, Marina; Sugarman, Ryan; Stadler, Zsofia; Yaeger, Rona; Smith, J. Joshua; Rousseau, Benoit; Argiles, Guillem; Patel, Miteshkumar; Desai, Avni; Saltz, Leonard B.; Widmar, Maria; Iyer, Krishna; Zhang, Janie; Gianino, Nicole; Crane, Christopher; Romesser, Paul B.; Pappou, Emmanouil P.; Paty, Philip; Garcia-Aguilar, Julio; Gonen, Mithat; Gollub, Marc; Weiser, Martin R.; Schalper, Kurt A.; Diaz, Luis A. (23 يونيو 2022). "PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer". New England Journal of Medicine. 386 (25): 2363–76. doi:10.1056/NEJMoa2201445. ISSN 0028-4793. PMC 9492301. PMID 35660797. S2CID 249395846.
  26. ^ "Trastuzumab Deruxtecan Leads to Longer PFS and OS Compared with Chemotherapy in Previously Treated HER2-Low Unresectable or Metastatic Breast Cancer". www.esmo.org. Retrieved 21 يوليو 2022.
  27. ^ Modi, Shanu; Jacot, William; Yamashita, Toshinari; Sohn, Joohyuk; Vidal, Maria; Tokunaga, Eriko; Tsurutani, Junji; Ueno, Naoto T.; Prat, Aleix; Chae, Yee Soo; Lee, Keun Seok; Niikura, Naoki; Park, Yeon Hee; Xu, Binghe; Wang, Xiaojia; Gil-Gil, Miguel; Li, Wei; Pierga, Jean-Yves; Im, Seock-Ah; Moore, Halle C. F.; Rugo, Hope S.; Yerushalmi, Rinat; Zagouri, Flora; Gombos, Andrea; Kim, Sung-Bae; Liu, Qiang; Luo, Ting; Saura, Cristina; Schmid, Peter; Sun, Tao; Gambhire, Dhiraj; Yung, Lotus; Wang, Yibin; Singh, Jasmeet; Vitazka, Patrik; Meinhardt, Gerold; Harbeck, Nadia; Cameron, David A. (5 يونيو 2022). "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer". New England Journal of Medicine (in الإنجليزية). 387 (1): 9–20. doi:10.1056/NEJMoa2203690. hdl:2445/197309. PMC 10561652. PMID 35665782. S2CID 249418284.
  28. ^ "Scientists harness light therapy to target and kill cancer cells in world first". The Guardian. 17 يونيو 2022. Retrieved 21 يونيو 2022.
  29. ^ Mączyńska, Justyna; Raes, Florian; Da Pieve, Chiara; Turnock, Stephen; Boult, Jessica K. R.; Hoebart, Julia; Niedbala, Marcin; Robinson, Simon P.; Harrington, Kevin J.; Kaspera, Wojciech; Kramer-Marek, Gabriela (21 يناير 2022). "Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy". BMC Medicine. 20 (1): 16. doi:10.1186/s12916-021-02213-z. ISSN 1741-7015. PMC 8780306. PMID 35057796.
  30. ^ أ ب Cerwenka A, Lanier LL (فبراير 2016). "Natural killer cell memory in infection, inflammation and cancer". Nature Reviews. Immunology. 16 (2): 112–123. doi:10.1038/nri.2015.9. PMID 26806484. S2CID 361806.
  31. ^ Zhu, Shaoming; Zhang, Tian; Zheng, Lei; Liu, Hongtao; Song, Wenru; Liu, Delong; Li, Zihai; Pan, Chong-xian (ديسمبر 2021). "Combination strategies to maximize the benefits of cancer immunotherapy". Journal of Hematology & Oncology. 14 (1): 156. doi:10.1186/s13045-021-01164-5. PMC 8475356. PMID 34579759.
  32. ^ Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR (مارس 2004). "A census of human cancer genes". Nature Reviews. Cancer. 4 (3): 177–183. doi:10.1038/nrc1299. PMC 2665285. PMID 14993899.
  33. ^ Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, Flanagan A, Teague J, Wooster R, Futreal PA, Stratton MR (يناير 2006). "COSMIC 2005". British Journal of Cancer. 94 (2): 318–322. doi:10.1038/sj.bjc.6602928. PMC 2361125. PMID 16421597.
  34. ^ Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V.The role of ATF-2 in oncogenesis" Bioessays 2008 Apr;30(4) 314-27.
  35. ^ Anand, P; Kunnumakkara, AB; Sundaram, C; Harikumar, KB; Tharakan, ST; Lai, OS; Sung, B; Aggarwal, BB (سبتمبر 2008). "Cancer is a preventable disease that requires major lifestyle changes". Pharmaceutical Research. 25 (9): 2097–116. doi:10.1007/s11095-008-9661-9. PMC 2515569. PMID 18626751. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  36. ^ Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de Gonzalez A, Hartge P, Adami HO, Blair CK, Borch KB, Boyd E, Check DP, Fournier A, Freedman ND, Gunter M, Johannson M, Khaw KT, Linet MS, Orsini N, Park Y, Riboli E, Robien K, Schairer C, Sesso H, Spriggs M, Van Dusen R, Wolk A, Matthews CE, Patel AV (2016). "Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults". JAMA Intern Med. 176 (6): 816–25. doi:10.1001/jamainternmed.2016.1548. PMC 5812009. PMID 27183032.
  37. ^ أ ب ت ث ج Wicki, A; Hagmann, J (9 سبتمبر 2011). "Diet and cancer". Swiss Medical Weekly. 141: w13250. doi:10.4414/smw.2011.13250. PMID 21904992. {{cite journal}}: Unknown parameter |nopp= ignored (|no-pp= suggested) (help)
  38. ^ أ ب Stewart, Bernard W.; Wild, Christopher P., eds. (2014). "Ch. 2: Cancer Etiology § 6 Diet, obesity and physical activity". World Cancer Report 2014. World Health Organization. pp. 124–33. ISBN 9789283204299.
  39. ^ Key, TJ (4 يناير 2011). "Fruit and vegetables and cancer risk". British Journal of Cancer. 104 (1): 6–11. doi:10.1038/sj.bjc.6606032. PMC 3039795. PMID 21119663.
  40. ^ Joshi, AD; Corral, R; Catsburg, C; Lewinger, JP; Koo, J; John, EM; Ingles, SA; Stern, MC (2012). "Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: Results from a multiethnic case-control study". Carcinogenesis. 33 (11): 2108–18. doi:10.1093/carcin/bgs242. PMC 3584966. PMID 22822096. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  41. ^ Zheng, W; Lee, SA (2009). "Well-done meat intake, heterocyclic amine exposure, and cancer risk". Nutrition and Cancer. 61 (4): 437–46. doi:10.1080/01635580802710741. PMC 2769029. PMID 19838915.
  42. ^ Ferguson, LR (فبراير 2010). "Meat and cancer". Meat Science. 84 (2): 308–13. doi:10.1016/j.meatsci.2009.06.032. PMID 20374790.
  43. ^ أ ب ت Park, S; Bae, J; Nam, BH; Yoo, KY (2008). "Aetiology of cancer in Asia" (PDF). Asian Pacific Journal of Cancer Prevention. 9 (3): 371–80. PMID 18990005.
  44. ^ Yu, Chengbo; Cao, Qing; Chen, Ping; Yang, Shigui; Deng, Min; Wang, Yugang; Li, Lanjuan (2016). "An updated dose–response meta-analysis of coffee consumption and liver cancer risk". Scientific Reports. 6 (1). doi:10.1038/srep37488. ISSN 2045-2322. PMC 5133591. PMID 27910873.
  45. ^ Brenner, H; Rothenbacher, D; Arndt, V (2009). "Epidemiology of Stomach Cancer". In Verma, Mukesh (ed.). Cancer Epidemiology: Volume 2: Modifiable Factors. Methods in Molecular Biology. Vol. 472. pp. 467–77. doi:10.1007/978-1-60327-492-0_23. ISBN 9781603274913. PMC 2166976. PMID 19107449.
  46. ^ Buell, P; Dunn, JE (مايو 1965). "Cancer mortality among Japanese Issei and Nisei of California". Cancer. 18 (5): 656–64. doi:10.1002/1097-0142(196505)18:5<656::AID-CNCR2820180515>3.0.CO;2-3. PMID 14278899.
  47. ^ Clifton, Katherine K.; Ma, Cynthia X.; Fontana, Luigi; Peterson, Lindsay L. (نوفمبر 2021). "Intermittent fasting in the prevention and treatment of cancer". CA: A Cancer Journal for Clinicians (in الإنجليزية). 71 (6): 527–546. doi:10.3322/caac.21694. ISSN 0007-9235. PMID 34383300. S2CID 236989849.
  48. ^ Manoogian, Emily N. C.; Panda, Satchidananda (1 أكتوبر 2017). "Circadian rhythms, time-restricted feeding, and healthy aging". Ageing Research Reviews (in الإنجليزية). 39: 59–67. doi:10.1016/j.arr.2016.12.006. ISSN 1568-1637. PMC 5814245. PMID 28017879.
  49. ^ Brandhorst, Sebastian; Longo, Valter D. (2016). "Fasting and Caloric Restriction in Cancer Prevention and Treatment". Metabolism in Cancer. Recent Results in Cancer Research (in الإنجليزية). Vol. 207. Springer. pp. 241–266. doi:10.1007/978-3-319-42118-6_12. ISBN 978-3-319-42116-2. PMC 7476366. PMID 27557543. S2CID 42198775.
  50. ^ Alidadi, Mona; Banach, Maciej; Guest, Paul C.; Bo, Simona; Jamialahmadi, Tannaz; Sahebkar, Amirhossein (1 أغسطس 2021). "The effect of caloric restriction and fasting on cancer". Seminars in Cancer Biology (in الإنجليزية). 73: 30–44. doi:10.1016/j.semcancer.2020.09.010. ISSN 1044-579X. PMID 32977005. S2CID 221938415.
  51. ^ Ibrahim, Ezzeldin M.; Al-Foheidi, Meteb H.; Al-Mansour, Mubarak M. (1 مايو 2021). "Energy and caloric restriction, and fasting and cancer: a narrative review". Supportive Care in Cancer. 29 (5): 2299–2304. doi:10.1007/s00520-020-05879-y. PMC 7981322. PMID 33190181. S2CID 226945778.
  52. ^ Hofer, Sebastian J.; Davinelli, Sergio; Bergmann, Martina; Scapagnini, Giovanni; Madeo, Frank (2021). "Caloric Restriction Mimetics in Nutrition and Clinical Trials". Frontiers in Nutrition. 8: 717343. doi:10.3389/fnut.2021.717343. PMC 8450594. PMID 34552954.
  53. ^ Madeo, Frank; Eisenberg, Tobias; Pietrocola, Federico; Kroemer, Guido (26 يناير 2018). "Spermidine in health and disease". Science (in الإنجليزية). 359 (6374): eaan2788. doi:10.1126/science.aan2788. ISSN 0036-8075. PMID 29371440. S2CID 206659415.
  54. ^ Imran, Muhammad; Aslam Gondal, Tanweer; Atif, Muhammad; Shahbaz, Muhammad; Batool Qaisarani, Tahira; Hanif Mughal, Muhammad; Salehi, Bahare; Martorell, Miquel; Sharifi-Rad, Javad (أغسطس 2020). "Apigenin as an anticancer agent". Phytotherapy Research (in الإنجليزية). 34 (8): 1812–28. doi:10.1002/ptr.6647. ISSN 0951-418X. PMID 32059077. S2CID 211122428.
  55. ^ Shukla, Sanjeev; Gupta, Sanjay (1 يونيو 2010). "Apigenin: A Promising Molecule for Cancer Prevention". Pharmaceutical Research. 27 (6): 962–978. doi:10.1007/s11095-010-0089-7. PMC 2874462. PMID 20306120.
  56. ^ Shankar, Eswar; Goel, Aditi; Gupta, Karishma; Gupta, Sanjay (1 ديسمبر 2017). "Plant Flavone Apigenin: an Emerging Anticancer Agent". Current Pharmacology Reports. 3 (6): 423–446. doi:10.1007/s40495-017-0113-2. PMC 5791748. PMID 29399439.
  57. ^ Samadi, Parisa; Sarvarian, Parisa; Gholipour, Elham; Asenjan, Karim Shams; Aghebati-Maleki, Leili; Motavalli, Roza; Hojjat-Farsangi, Mohammad; Yousefi, Mehdi (أكتوبر 2020). "Berberine: A novel therapeutic strategy for cancer". IUBMB Life (in الإنجليزية). 72 (10): 2065–79. doi:10.1002/iub.2350. ISSN 1521-6543. PMID 32735398. S2CID 220893166.
  58. ^ Zhong, Xiao-Dan; Chen, Li-Juan; Xu, Xin-Yang; Liu, Yan-Jun; Tao, Fan; Zhu, Ming-Hui; Li, Chang-Yun; Zhao, Dan; Yang, Guan-Jun; Chen, Jiong (2022). "Berberine as a potential agent for breast cancer therapy". Frontiers in Oncology. 12: 993775. doi:10.3389/fonc.2022.993775. PMC 9480097. PMID 36119505.
  59. ^ Wang, Ye; Liu, Yanfang; Du, Xinyang; Ma, Hong; Yao, Jing (30 يناير 2020). "The Anti-Cancer Mechanisms of Berberine: A Review". Cancer Management and Research. 12: 695–702. doi:10.2147/CMAR.S242329. PMC 6996556. PMID 32099466.
  60. ^ Vlavcheski, Filip; O’Neill, Eric J.; Gagacev, Filip; Tsiani, Evangelia (يناير 2022). "Effects of Berberine against Pancreatitis and Pancreatic Cancer". Molecules. 27 (23): 8630. doi:10.3390/molecules27238630. PMC 9738201. PMID 36500723.
  61. ^ Guamán Ortiz, Luis Miguel; Lombardi, Paolo; Tillhon, Micol; Scovassi, Anna Ivana (أغسطس 2014). "Berberine, an Epiphany Against Cancer". Molecules. 19 (8): 12349–67. doi:10.3390/molecules190812349. PMC 6271598. PMID 25153862.
  62. ^ Su, Chao; Li, Nan; Ren, Ruru; Wang, Yingli; Su, Xiaojuan; Lu, Fangfang; Zong, Rong; Yang, Lingling; Ma, Xueqin (يناير 2021). "Progress in the Medicinal Value, Bioactive Compounds, and Pharmacological Activities of Gynostemma pentaphyllum". Molecules. 26 (20): 6249. doi:10.3390/molecules26206249. PMC 8540791. PMID 34684830.
  63. ^ Pu, Wei-ling; Zhang, Meng-ying; Bai, Ru-yu; Sun, Li-kang; Li, Wen-hua; Yu, Ying-li; Zhang, Yue; Song, Lei; Wang, Zhao-xin; Peng, Yan-fei; Shi, Hong; Zhou, Kun; Li, Tian-xiang (1 يناير 2020). "Anti-inflammatory effects of Rhodiola rosea L.: A review". Biomedicine & Pharmacotherapy (in الإنجليزية). 121: 109552. doi:10.1016/j.biopha.2019.109552. ISSN 0753-3322. PMID 31715370. S2CID 207938536.
  64. ^ Magani, Sri Krishna Jayadev; Mupparthi, Sri Durgambica; Gollapalli, Bhanu Prakash; Shukla, Dhananjay; Tiwari, A. K.; Gorantala, Jyotsna; Yarla, Nagendra Sastry; Tantravahi, Srinivasan (2020). "Salidroside — Can it be a Multifunctional Drug?". Current Drug Metabolism (in الإنجليزية). 21 (7): 512–524. doi:10.2174/1389200221666200610172105. PMID 32520682. S2CID 219588131.
  65. ^ "Federally Funded Cancer Research". asco.org. 8 فبراير 2016. Archived from the original on 23 أبريل 2018. Retrieved 9 مايو 2018.
  66. ^ أ ب ت ث Eckhouse S, Sullivan R (يوليو 2006). "A survey of public funding of cancer research in the European union". PLOS Medicine. 3 (7): e267. doi:10.1371/journal.pmed.0030267. PMC 1513045. PMID 16842021.
  67. ^ "NCI Budget Fact Book". National Cancer Institute (in الإنجليزية). 10 مايو 2022.
  68. ^ Alberts B, Kirschner MW, Tilghman S, Varmus H (أبريل 2014). "Rescuing US biomedical research from its systemic flaws". Proceedings of the National Academy of Sciences of the United States of America. 111 (16): 5773–7. Bibcode:2014PNAS..111.5773A. doi:10.1073/pnas.1404402111. PMC 4000813. PMID 24733905.
  69. ^ Kolata G (23 أبريل 2009). "Advances Elusive in the Drive to Cure Cancer". The New York Times. Archived from the original on 14 يناير 2012. Retrieved 29 ديسمبر 2009.
  70. ^ Kolata G (27 يونيو 2009). "Grant System Leads Cancer Researchers to Play It Safe". The New York Times. Archived from the original on 8 يونيو 2011. Retrieved 29 ديسمبر 2009.
  71. ^ Leaf C (22 مارس 2004). "Why We're Losing The War on Cancer". Fortune Magazine (CNN Money). Archived from the original on 2 مايو 2014.
  72. ^ "Help Conquer Cancer". 19 نوفمبر 2007. Archived from the original on 16 نوفمبر 2007. Retrieved 19 نوفمبر 2007.
  73. ^ أ ب Klein, Harry; Mazor, Tali; Siegel, Ethan; Trukhanov, Pavel; Ovalle, Andrea; Vecchio Fitz, Catherine Del; Zwiesler, Zachary; Kumari, Priti; Van Der Veen, Bernd; Marriott, Eric; Hansel, Jason; Yu, Joyce; Albayrak, Adem; Barry, Susan; Keller, Rachel B.; MacConaill, Laura E.; Lindeman, Neal; Johnson, Bruce E.; Rollins, Barrett J.; Do, Khanh T.; Beardslee, Brian; Shapiro, Geoffrey; Hector-Barry, Suzanne; Methot, John; Sholl, Lynette; Lindsay, James; Hassett, Michael J.; Cerami, Ethan (6 أكتوبر 2022). "MatchMiner: an open-source platform for cancer precision medicine". npj Precision Oncology. 6 (1): 69. doi:10.1038/s41698-022-00312-5. PMC 9537311. PMID 36202909.
  74. ^ "Researchers report genomic profiling from more than 110,000 tumors". News-Medical.net (in الإنجليزية). 19 يوليو 2022. Retrieved 20 نوفمبر 2022.
  75. ^ "Cancer Awareness Dates". cancer.net. 19 ديسمبر 2013. Archived from the original on 9 ديسمبر 2017. Retrieved 9 مايو 2018.

External links

تمّ الاسترجاع من "https://www.marefa.org/w/index.php?title=أبحاث_السرطان&oldid=4105226"